Scientists: Bladder cancer destroyed by the common cold virus

Scientists: Bladder cancer destroyed by the common cold virus

A strain of the common cold has successfully targeted and destroyed bladder cancer cells, an exciting study has revealed. The surprising results suggest the simple cold could revolutionize future cancer treatment. Scientists from the University of Surrey and Royal Surrey...
read more
The 30 Billion Supplements Sector Has a Problem: Food Supplements Don’t Work

The 30 Billion Supplements Sector Has a Problem: Food Supplements Don’t Work

A 10-year observation study of over 30,000 people has found that some vitamins and minerals can help you avoid cardiovascular disease, but only if your body gets your beneficial nutrients from food, not from food supplements. The study, published this...
read more
U.S. Charges Indivior With Organizing Multibillion-Dollar Fraud

U.S. Charges Indivior With Organizing Multibillion-Dollar Fraud

Indivior PLC shares are down 77% to a new record low after US investigators have accused the company of fraud against the opioid drug addicts with their own drug Suboxone Film. The total amount of all fraud is estimated at...
read more
FDA finds asbestos in make-up at Claire’s

FDA finds asbestos in make-up at Claire’s

The U.S. Food and Drug Administration on Tuesday warned consumers not to use particular cosmetic products sold at Claire’s retail branches after they were found to contain asbestos, a known dangerous carcinogen. Samples of Claire’s eye shadows batc...
read more
GE to sell BioPharma business to Danaher for $21.4B

GE to sell BioPharma business to Danaher for $21.4B

Shares of General Electric Co. (symbol: GE) soar 10% in premarket trade Monday, after the conglomerate agreed to sell its biopharma branch to Danaher Corp. (symbol: DHR) for $21.4 billion. Transaction is payable in cash. “Today’s transaction is a...
read more
Spark Therapeutics +122% after the acquisition news by Roche

Spark Therapeutics +122% after the acquisition news by Roche

Swiss pharmaceutical company Roche Holding AG announced that it has reached a final agreement for acquisition of Spark Therapeutics from Philadelphia. Roche offered $114.50 for each share of Spark Therapeutics, which is 122% more than Friday’s closing pr...
read more
Outrage as Once-Free Drug Now Costs $375,000

Outrage as Once-Free Drug Now Costs $375,000

Sen. Bernie Sanders (I-Vt.) is demanding to know why a pharmaceutical company has slapped a $375,000 list price on a drug that patients used to get for free. Sanders accused Patrick McEnany, president and CEO of Catalyst Pharmaceuticals Inc., of...
read more
$3.5 Trillion A Year – America’s Health Care System

$3.5 Trillion A Year – America’s Health Care System

If the U.S. health care system was a country, it would have the fifth largest GDP on the entire planet.  At this point only the United States, China, Japan and Germany have a GDP that is larger than the 3.5 trillion...
read more